Stay updated with breaking news from Sprint Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
.jpg)
A collaborative team effort led by the Tumor Immunotherapy and Microenvironment (TIME) group at the Luxembourg Institute of Health, along with Sprint Bioscience and Karolinska Institutet (Sweden) has discovered a promising new approach for cancer treatment. Click to read more...
Day One Biopharmaceuticals has signed a license agreement and research partnership with Sprint Bioscience to advance VRK1 programme.
Day One receives an exclusive license to develop and commercialize small molecule drug candidates for pediatric and adult cancers with high unmet need Collaboration augments Day One’s portfolio... -Today at 08:02 am- MarketScreener
With effect from November 01, 2022, the unit rights in Sprint Bioscience AB will be traded on First North Premier Growth Market. Trading will continue up until and including November 10, 2022. Instrument:
/PRNewswire/ -- Immunovia AB (publ) ("Immunovia"), a diagnostic company that develops and sells highly accurate blood tests for the early detection of cancer,...